Follow
Dr.M.Makesh Kumar
Dr.M.Makesh Kumar
Scientist "D" ( Medical ), National Institute for Research in Tuberculosis , ICMR, MoHFW,GoI.
Verified email at icmr.gov.in
Title
Cited by
Cited by
Year
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients
MS Jawahar, VV Banurekha, CN Paramasivan, F Rahman, ...
PLoS One 8 (7), e67030, 2013
1222013
Role of LTA4H polymorphism in tuberculosis-associated immune reconstitution inflammatory syndrome occurrence and clinical severity in patients infected with HIV
G Narendran, D Kavitha, R Karunaianantham, L Gil-Santana, ...
PLoS One 11 (9), e0163298, 2016
212016
4‐month moxifloxacin containing regimens in the treatment of patients with sputum‐positive pulmonary tuberculosis in South India–a randomised clinical trial
B Velayutham, MS Jawahar, D Nair, P Navaneethapandian, C Ponnuraja, ...
Tropical Medicine & International Health 25 (4), 483-495, 2020
152020
Effect of moxifloxacin on QTc interval in adults with pulmonary tuberculosis
D Nair, B Velayutham, M Marimuthu, PGD Navaneethapandian, ...
The National medical journal of India 31 (1), 58-59, 2018
62018
Assessment of panel slides prepared by phenol ammonium sulphate and NALC methods for proficiency testing
R Radhakrishnan, MMP Kumar, S Prabuseenivasan, S Anbarasu, ...
The International journal of tuberculosis and lung disease 16 (3), 394-397, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–5